195 related articles for article (PubMed ID: 28320405)
1. Urinary collagen degradation products as early markers of progressive renal fibrosis.
Hijmans RS; Rasmussen DG; Yazdani S; Navis G; van Goor H; Karsdal MA; Genovese F; van den Born J
J Transl Med; 2017 Mar; 15(1):63. PubMed ID: 28320405
[TBL] [Abstract][Full Text] [Related]
2. Serum and urine markers of collagen degradation reflect renal fibrosis in experimental kidney diseases.
Papasotiriou M; Genovese F; Klinkhammer BM; Kunter U; Nielsen SH; Karsdal MA; Floege J; Boor P
Nephrol Dial Transplant; 2015 Jul; 30(7):1112-21. PubMed ID: 25784725
[TBL] [Abstract][Full Text] [Related]
3. Targeting tubulointerstitial remodeling in proteinuric nephropathy in rats.
Yazdani S; Hijmans RS; Poosti F; Dam W; Navis G; van Goor H; van den Born J
Dis Model Mech; 2015 Aug; 8(8):919-30. PubMed ID: 26035383
[TBL] [Abstract][Full Text] [Related]
4. A non-invasive biomarker of type III collagen degradation reflects ischaemia reperfusion injury in rats.
Rasmussen DGK; Nielsen PM; Kasab-Oglo ÖY; Nielsen SH; Kierulf-Lassen C; Karsdal MA; Genovese F; Nørregaard R
Nephrol Dial Transplant; 2019 Aug; 34(8):1301-1309. PubMed ID: 30535162
[TBL] [Abstract][Full Text] [Related]
5. Selective lymphocyte inhibition by FTY720 slows the progressive course of chronic anti-thy 1 glomerulosclerosis.
Peters H; Martini S; Wang Y; Shimizu F; Kawachi H; Krämer S; Neumayer HH
Kidney Int; 2004 Oct; 66(4):1434-43. PubMed ID: 15458436
[TBL] [Abstract][Full Text] [Related]
6. Exogenous bone morphogenetic protein-7 fails to attenuate renal fibrosis in rats with overload proteinuria.
Ikeda Y; Jung YO; Kim H; Oda T; López-Guisa J; Maruvada R; Diamond DL; Martin KJ; Wing D; Cai X; Eddy AA
Nephron Exp Nephrol; 2004; 97(4):e123-35. PubMed ID: 15331933
[TBL] [Abstract][Full Text] [Related]
7. Modulation of osteopontin in proteinuria-induced renal interstitial fibrosis.
Kramer AB; Ricardo SD; Kelly DJ; Waanders F; van Goor H; Navis G
J Pathol; 2005 Dec; 207(4):483-92. PubMed ID: 16211543
[TBL] [Abstract][Full Text] [Related]
8. Tissue turnover of collagen type I, III and elastin is elevated in the PCLS model of IPF and can be restored back to vehicle levels using a phosphodiesterase inhibitor.
Hansen NU; Karsdal MA; Brockbank S; Cruwys S; Rønnow S; Leeming DJ
Respir Res; 2016 Jul; 17(1):76. PubMed ID: 27411390
[TBL] [Abstract][Full Text] [Related]
9. Turnover of type III collagen reflects disease severity and is associated with progression and microinflammation in patients with IgA nephropathy.
Genovese F; Boor P; Papasotiriou M; Leeming DJ; Karsdal MA; Floege J
Nephrol Dial Transplant; 2016 Mar; 31(3):472-9. PubMed ID: 26311218
[TBL] [Abstract][Full Text] [Related]
10. Progression of chronic adriamycin nephropathy in leukopenic rats.
Ginevri F; Trivelli A; Mutti A; Bergamaschi E; Fabbretti G; Callea F; Salvidio G; Altieri P; Perfumo F; Ghiggeri GM
Nephron; 1993; 63(1):79-88. PubMed ID: 8446256
[TBL] [Abstract][Full Text] [Related]
11. Macrophages, myofibroblasts, and extracellular matrix accumulation in interstitial fibrosis of chronic progressive nephropathy in aged rats.
Nakatsuji S; Yamate J; Sakuma S
Vet Pathol; 1998 Sep; 35(5):352-60. PubMed ID: 9754540
[TBL] [Abstract][Full Text] [Related]
12. The lymphocyte migration inhibitor FTY720 attenuates experimental hypertensive nephropathy.
Krämer S; Binder E; Loof T; Wang-Rosenke Y; Martini S; Khadzhynov D; Budde K; Neumayer HH; Peters H
Am J Physiol Renal Physiol; 2009 Jul; 297(1):F218-27. PubMed ID: 19439518
[TBL] [Abstract][Full Text] [Related]
13. Effects of dietary salt restriction on renal progression and interstitial fibrosis in adriamycin nephrosis.
Park JS; Kim S; Jo CH; Oh IH; Kim GH
Kidney Blood Press Res; 2014; 39(1):86-96. PubMed ID: 25034642
[TBL] [Abstract][Full Text] [Related]
14. Urinary vitamin D binding protein: a potential novel marker of renal interstitial inflammation and fibrosis.
Mirković K; Doorenbos CR; Dam WA; Lambers Heerspink HJ; Slagman MC; Nauta FL; Kramer AB; Gansevoort RT; van den Born J; Navis G; de Borst MH
PLoS One; 2013; 8(2):e55887. PubMed ID: 23409077
[TBL] [Abstract][Full Text] [Related]
15. Effect of combining ACE inhibition with aldosterone blockade on proteinuria and renal damage in experimental nephrosis.
Kramer AB; van der Meulen EF; Hamming I; van Goor H; Navis G
Kidney Int; 2007 Mar; 71(5):417-24. PubMed ID: 17213874
[TBL] [Abstract][Full Text] [Related]
16. FTY720 ameliorates renal fibrosis by simultaneously affecting leucocyte recruitment and TGF-β signalling in fibroblasts.
Tian T; Zhang J; Zhu X; Wen S; Shi D; Zhou H
Clin Exp Immunol; 2017 Oct; 190(1):68-78. PubMed ID: 28658504
[TBL] [Abstract][Full Text] [Related]
17. Urinary and serum type III collagen: markers of renal fibrosis.
Soylemezoglu O; Wild G; Dalley AJ; MacNeil S; Milford-Ward A; Brown CB; el Nahas AM
Nephrol Dial Transplant; 1997 Sep; 12(9):1883-9. PubMed ID: 9306339
[TBL] [Abstract][Full Text] [Related]
18. Less contribution of mast cells to the progression of renal fibrosis in Rat kidneys with chronic renal failure.
Baba A; Tachi M; Ejima Y; Endo Y; Toyama H; Saito K; Abe N; Yamauchi M; Miura C; Kazama I
Nephrology (Carlton); 2017 Feb; 22(2):159-167. PubMed ID: 26840502
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidney.
Badid C; Vincent M; McGregor B; Melin M; Hadj-Aissa A; Veysseyre C; Hartmann DJ; Desmouliere A; Laville M
Kidney Int; 2000 Jul; 58(1):51-61. PubMed ID: 10886549
[TBL] [Abstract][Full Text] [Related]
20. Collagen degradation products measured in serum can separate ovarian and breast cancer patients from healthy controls: A preliminary study.
Bager CL; Willumsen N; Leeming DJ; Smith V; Karsdal MA; Dornan D; Bay-Jensen AC
Cancer Biomark; 2015; 15(6):783-8. PubMed ID: 26406420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
